Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS): first analysis on survival-Reference-Cited by-同舟云学术

Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS): first analysis on survival

Published:2018-06-22 Issue:6 Volume:23 Page:1148-1159
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Ito Kazuto^ORCID,Saito Shiro,Yorozu Atsunori,Kojima Shinsuke,Kikuchi Takashi,Higashide Satoshi,Aoki Manabu,Koga Hirofumi,Satoh Takefumi,Ohashi Toshio,Nakamura Katsumasa,Katayama Norihisa,Tanaka Nobumichi,Nakano Masahiro,Shigematsu Naoyuki,Dokiya Takushi,Fukushima Masanori,Takahashi Yutaka,Tsukiyama Iwao,Nasu Yasutomo,Harada Masaoki,Fukagai Takashi,Yamashita Takashi,Matsubara Akio,Igawa Mikio,Egawa Shin,Kakehi Yoshiyuki,Katsuoka Youji,Kanetake Hiroshi,Kubota Yoshinobu,Kumon Hiromi,Yamasaki Ichiro,Suzuki Kazuhiro,Deguchi Takashi,Ueno Munehisa,Naito Seiji,Namiki Mikio,Baba Shiro,Hayakawa Kazushige,Hirao Yoshihiko,Fujioka Tomoaki,Horie Shigeo,Miki Tsuneharu,Murai Masaru,Yoshida Hideki,Itami Jun,Inoue Toshihiko,Imai Yutaka,Kataoka Masaaki,Kubo Atsushi,Shibuya Hitoshi,Nishio Masamichi,Tanaka Hiroyoshi,Tanaka Yoshiaki,Teramukai Satoshi,Harada Chikako,Yamashiro Kouichi,Kiba Takayoshi,Kitagawa Shin-ichi,Uno Emiko,Nishimura Tsutomu,Kinoshita Fumie,Iida Shinya,Maruo Shinichiro,Miyakoda Keiko,Daimon Takashi,Kawamoto Atsuhiko,Kaneda Hideaki,Yoshidomi Mikio,Nishiyama Toru,Yagi Yasuto,Namitome Ryo,Toya Kazuhito,Koike Naoyoshi,Yoshida Kayo,Tabata Kenichi,Tsumura Hideyasu,Kimura Masaki,Ishiyama Hiromichi,Kotani Shouko,Tanaka Nobumichi,Kondo Hideaki,Fujimoto Kiyohide,Hasegawa Masatoshi,Tamamoto Tetsuro,Asakawa Isao,Nishizawa Shuji,Hashida Iwao,Takezawa Yutaka,Harada Kousaku,Tanji Susumu,Sato Kensuke,Matsuura Tomohiko,Ariga Hisanori,Ehara Shigeru,Nakamura Ryuji,Nakano Masahiro,Hayashi Shinya,Ohtakara Kazuhiro,Kihara Kazunori,Hayashi Keiji,Okamoto Keisei,Sho Keizen,Kono Naoaki,Okihara Koji,Kobayashi Kana,Betsuku Kensuke,Katayama Norihisa,Takemoto Mitsuhiro,Kanazawa Susumu,Miyakubo Mai,Kato Hiroyuki,Noda Haruhisa,Nagashima Junichi,Harabayashi Toru,Nagamori Satoshi,Nishiyama Noriaki,Kanemura Mikiro,Aruga Takashi,Fukumori Tomoharu,Furutani Shunsuke,Kotoh Shuji,Masumoto Hiroshi,Yamasaki Takenari,Kawashima Kiyotaka,Inoue Koichi,Matsubara Akio,Teishima Jun,Kenjo Masahiro,Hashine Katsuyoshi,Tatsugami Katsunori,Kuroiwa Kentaro,Inokuchi Junichi,Ohga Saiji,Nakamura Katsumasa,Sasaki Tomonari,Shuin Taro,Kariya Shinji,Miki Kenta,Sasaki Hiroshi,Kido Masahito,Yonese Junji,Kozuka Takuyo,Sumura Masahiro,Uchida Nobue,Morita Masashi,Ogawa Yoshio,Hamada Kenji,Nakai Yasutomo,Yoshioka Yasuo,Sakai Hideki,Hayashi Nobuyuki,Masumori Naoya,Hori Masakazu,Hasumi Masaru,Kudo Shigehiro,Uemura Hiroji,Hayashi Narihiko,Sano Futoshi,Ogino Ichiro,Ishikawa Akira,Shiraishi Kenshiro,Muraishi Osamu,Nakamura Naoki,Shiroki Ryoichi,Ito Fumitaka,Tomioka Susumu,Ohta Sayako,Yokoyama Osamu,Shioura Hiroki,Hioka Takaya,Suzuki Keishiro,Kageyama Yukio,Saito Yoshihiro,Kikugawa Tadahiko,Nishikawa Atsushi,Nagata Hirohiko,Sugawara Akitomo,Kawakita Shigenari,Shiga Yoshiko,Momma Tetsuo,Yamashita Shoji,

Funder

Health Labor Sciences Research Grant from the Japanese Ministry of Health, Labor and Welfare

Foundation for Biomedical Research and Innovation

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

https://link.springer.com/article/10.1007/s10147-018-1309-0/fulltext.html

Reference27 articles.

1. International Agency for Research on Cancer (IARC) (2012) Prostate cancer. Estimated incidence, mortality and prevalence worldwide in 2012. Globocan 2012. Available via DIALOG. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. Accessed April 2016

2. Ito K (2014) Prostate cancer in Asian men. Nat Rev Urol 11:197–212

3. Grimm P, Billiet I, Bostwick D et al (2012) Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. BJU Int 109(Suppl 1):22–29

4. Peinemann F, Grouven U, Bartel C et al (2011) Permanent interstitial low-dose-rate brachytherapy for patients with localised prostate cancer: a systematic review of randomised and nonrandomised controlled clinical trials. Eur Urol 60:881–893

5. Stone NN, Stock RG (2007) Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 years. Urology 69:338–342

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Future Treatment Strategies for Cancer Patients Combining Targeted Alpha Therapy with Pillars of Cancer Treatment: External Beam Radiation Therapy, Checkpoint Inhibition Immunotherapy, Cytostatic Chemotherapy, and Brachytherapy;Pharmaceuticals;2024-08-05

2. Prostate brachytherapy seed migration to the right renal artery due to right‐to‐left shunting across a patent foramen ovale;IJU Case Reports;2024-03-07

3. Trimodality Therapy With Iodine-125 Brachytherapy, External Beam Radiation Therapy, and Short- or Long-Term Androgen Deprivation Therapy for High-Risk Localized Prostate Cancer: Results of a Multicenter, Randomized Phase 3 Trial (TRIP/TRIGU0907);International Journal of Radiation Oncology*Biology*Physics;2024-02

4. Radiotherapy in prostatic cancer;Revisiones en Cáncer;2024

5. The prognosis of patients with prostate cancer receiving permanent seed implantation stratified by prostate volume: Should we be reluctant to treat with brachytherapy because of a very small prostate (<15 cc)?;Radiotherapy and Oncology;2023-11